Re RNS - Ethics Approval Confirmed17 Feb 2021 10:21
Not priced in at all Steadfast! We've a long way off fair value for our core businesses because of Invesco selling, let alone this news. This opens up £46 million of earnings. At 3 times earnings, that gives us another £138 million m/cap. I know that's in simple terms, but gives up something to work from. Way, way undervalued now. ATB